Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

During the Trading Day
11.54 +0.69 / +6.36%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.82 -0.72 / -6.24%
Volume: 3.8K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 1
Quarter 2
Quarter 3
Quarter 4
Revenue and IncomeNet Revenues19.1M17.4M31.5M53.8M
Cost of Goods Sold10.0M8.7M11.7M14.8M
Depreciation And Amortization2.2M2.0M10.2M18.7M
Operating ExpensesGross Income6.9M6.7M9.6M20.3M
General Expenses14.6M14.1M15.3M22.9M
Research And Development968.9K345.6K290.0K2.3M
Total Operating Expenses26.7M24.8M37.2M56.4M
Non-Operating ExpensesOperating Income-7.7M-7.4M-5.7M-2.5M
Extraordinary Charge-6.5M----0.00
Interest Expense On Debt1.4M2.3M5.3M10.0M
Other Expenses0.00-368.1K6.0K-82.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.4M-10.0M-11.0M-12.6M
Income Taxes-5.9M-3.7M-655.0K-4.8M
Net Income-9.5M-6.2M-11.7M-7.8M
Shares To Calculate EPSShares To Calculate EPS37.3M37.8M38.1M38.3M
Shares To Calculate EPS Diluted37.3M37.8M38.1M38.3M
Earnings Per ShareEPS-$0.26-$0.16-$0.31-$0.20
EPS Diluted-$0.26-$0.16-$0.31-$0.20

To view my watchlist

Not a member yet?

Sign up now for a free account